Unknown

Dataset Information

0

Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.


ABSTRACT: Hotspot histone H3 mutations have emerged as drivers of oncogenesis in cancers of multiple lineages. Specifically, H3 lysine 36 to methionine (H3K36M) mutations are recurrently identified in chondroblastomas, undifferentiated sarcomas, and head and neck cancers. While the mutation reduces global levels of both H3K36 dimethylation (H3K36me2) and trimethylation (H3K36me3) by dominantly inhibiting their respective specific methyltransferases, the relative contribution of these methylation states to the chromatin and phenotypic changes associated with H3K36M remains unclear. Here, we specifically deplete H3K36me2 or H3K36me3 in mesenchymal cells, using CRISPR-Cas9 to separately knock out the corresponding methyltransferases NSD1/2 or SETD2. By profiling and comparing the epigenomic and transcriptomic landscapes of these cells with cells expressing the H3.3K36M oncohistone, we find that the loss of H3K36me2 could largely recapitulate H3.3K36M's effect on redistribution of H3K27 trimethylation (H3K27me3) and gene expression. Consistently, knockout of Nsd1/2, but not Setd2, phenocopies the differentiation blockade and hypersensitivity to the DNA-hypomethylating agent induced by H3K36M. Together, our results support a functional divergence between H3K36me2 and H3K36me3 and their nonredundant roles in H3K36M-driven oncogenesis.

SUBMITTER: Rajagopalan KN 

PROVIDER: S-EPMC7936350 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2021-02-23 | GSE160266 | GEO
| PRJNA672721 | ENA
| S-EPMC8534482 | biostudies-literature
| S-EPMC3523246 | biostudies-literature
| S-EPMC7661040 | biostudies-literature
| S-EPMC5224523 | biostudies-literature
| S-EPMC5824794 | biostudies-literature
| S-EPMC1247656 | biostudies-literature
| S-EPMC6351847 | biostudies-other
| S-EPMC3397264 | biostudies-literature